Vizient, Inc. released its new Spend Management Outlook representing the best estimate of the change in the price of pharmaceuticals, medical devices and supplies, capital equipment and services ...

Humira®, STELARA® (Janssen Biotech) and SKYRIZI® (AbbVie ... supplies critical to healthcare such as gloves, needles, syringes and certain face masks. While Vizient expects a limited effect ...

Locals near a needle exchange site in a Bronx park are cheering a councilman’s proposal to require city health workers to collect hundreds of discarded syringes littering the ground. Oswald ...

AbbVie's IL-23 inhibitor Skyrizi trailed some of its rivals in its first indication psoriasis, but has leapfrogged into first place in Crohn's disease after getting approval for the new indication ...

Established injectable drugs like Novartis' Cosentyx (secukinumab) and AbbVie's Skyrizi (risankizumab) have been shown in trials to achieve 75% skin clearance in roughly 80% of patients.